Randomized Trial: Treatment for Advanced and Refractory Desmoid Tumors Evaluated
8 Jan, 2019 | 17:29h | UTCSorafenib for Advanced and Refractory Desmoid Tumors – New England Journal of Medicine (link to abstract – $ for full-text)
Commentary: Sorafenib in Progressive, Symptomatic, or Recurrent Desmoid Tumors – The ASCO Post (free)